{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:23:38Z","timestamp":1777508618120,"version":"3.51.4"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Infect Dis Rep"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1007\/s11908-007-0021-4","type":"journal-article","created":{"date-parts":[[2007,4,18]],"date-time":"2007-04-18T16:30:22Z","timestamp":1176913822000},"page":"39-46","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Prevention and treatment of vivax malaria"],"prefix":"10.1007","volume":"9","author":[{"given":"J. Kevin","family":"Baird","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eli","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen L.","family":"Hoffman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,4,17]]},"reference":[{"issue":"1\u20132Suppl","key":"21_CR1","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4269\/ajtmh.2001.64.97","volume":"64","author":"K. Mendis","year":"2001","unstructured":"Mendis K, Sina BJ, Marchesini P, Carter R: The neglected burden of Plasmodium vivax malaria. Am J Trop Med Hyg 2001, 64(1\u20132 Suppl):97\u2013106.","journal-title":"Am J Trop Med Hyg"},{"key":"21_CR2","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3201\/eid1101.040519","volume":"11","author":"D.K. Kochar","year":"2005","unstructured":"Kochar DK, Saxena V, Singh N, et al.: Plasmodium vivax malaria. Emerg Infect Dis 2005, 11:132\u2013134.","journal-title":"Emerg Infect Dis"},{"key":"21_CR3","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.4269\/ajtmh.1982.31.1291","volume":"31","author":"W.A. Krotoski","year":"1982","unstructured":"Krotoski WA, Collins WE, Bray RS, et al.: Demonstration of hypnozoites in sporozoite-transmitted Plasmodium vivax infection. Am J Trop Med Hyg 1982, 31:1291\u20131293.","journal-title":"Am J Trop Med Hyg"},{"issue":"Pt1","key":"21_CR4","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1017\/S0031182000080999","volume":"110","author":"J.R. Glynn","year":"1995","unstructured":"Glynn JR, Bradley DJ: Inoculum size, incubation period and severity of malaria. Analysis of data from malaria therapy records. Parasitology 1995, 110(Pt 1):7\u201319.","journal-title":"Parasitology"},{"key":"21_CR5","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1086\/513990","volume":"175","author":"L.W. Church","year":"1997","unstructured":"Church LW, Le TP, Bryan JP, et al.: Clinical manifestations of Plasmodium falciparum malaria experimentally induced by mosquito challenge. J Infect Dis 1997, 175:915\u2013920.","journal-title":"J Infect Dis"},{"key":"21_CR6","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1128\/CMR.5.1.26","volume":"5","author":"F.B. Cogswell","year":"1992","unstructured":"Cogswell FB: The hypnozoite and relapse in primate malaria. Clin Microbiol Rev 1992, 5:26\u201335.","journal-title":"Clin Microbiol Rev"},{"key":"21_CR7","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1056\/NEJMoa021592","volume":"349","author":"E. Schwartz","year":"2003","unstructured":"Schwartz E, Praise M, Kozarsky P, Cetron M: Delayed onset of malaria: in travelers: Implications for chemoprophylaxis. N Engl J Med 2003, 349:1510\u20131516.","journal-title":"N Engl J Med"},{"key":"21_CR8","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1111\/j.1365-3156.2006.01635.x","volume":"11","author":"C.J. Hemmer","year":"2006","unstructured":"Hemmer CJ, Holst FG, Kern P, et al.: Stronger host response per parasitized erythrocyte in Plasmodium vivax or ovale than in Plasmodium falciparum malaria. Trop Med Int Health 2006, 11:817\u2013823.","journal-title":"Trop Med Int Health"},{"key":"21_CR9","first-page":"231","volume":"28","author":"K. Ravichandiran","year":"1996","unstructured":"Ravichandiran K, Sumitha K, Selvam RJ: Liver function tests in recurrent P. vivax malaria. Commun Dis 1996, 28:231\u2013240.","journal-title":"Commun Dis"},{"key":"21_CR10","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1590\/S1413-86702005000500011","volume":"9","author":"A.V. Lomar","year":"2005","unstructured":"Lomar AV, Vidal JE, Lomar FP, et al.: Acute respiratory distress syndrome due to vivax malaria: case report and literature review. Braz J Infect Dis 2005, 9:425\u2013430.","journal-title":"Braz J Infect Dis"},{"key":"21_CR11","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/tropej\/fmi069","volume":"52","author":"A.J. Rodriguez-Morales","year":"2006","unstructured":"Rodriguez-Morales AJ, Sanchez E, Vargas M, et al.: Anemia and thrombocytopenia in children with Plasmodium vivax malaria. J Trop Pediatr 2006, 52:49\u201351.","journal-title":"J Trop Pediatr"},{"key":"21_CR12","first-page":"18","volume":"39","author":"M.K. Mohapatra","year":"2002","unstructured":"Mohapatra MK, Padhiary KN, Mishra DP, Sethy G: Atypical manifestations of Plasmodium vivax malaria. Indian J Malariol 2002, 39:18\u201325.","journal-title":"Indian J Malariol"},{"key":"21_CR13","doi-asserted-by":"crossref","first-page":"230","DOI":"10.4269\/ajtmh.2002.67.230","volume":"67","author":"M.A. Beg","year":"2002","unstructured":"Beg MA, Khan R, Baig SM, et al.: Cerebral involvement in benign tertian malaria. Am J Trop Med Hyg 2002, 67:230\u2013232.","journal-title":"Am J Trop Med Hyg"},{"key":"21_CR14","first-page":"24","volume":"47","author":"K.S. Mehta","year":"2001","unstructured":"Mehta KS, Halankar AR, Makwana PD, et al.: Severe acute renal failure in malaria. J Postgrad Med 2001, 47:24\u201326.","journal-title":"J Postgrad Med"},{"key":"21_CR15","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s15010-006-4126-8","volume":"34","author":"H.R. Gockel","year":"2006","unstructured":"Gockel HR, Heidemann J, Lorenz D, Gockel I: Spontaneous splenic rupture in tertian malaria. Infection 2006, 34:43\u201345.","journal-title":"Infection"},{"key":"21_CR16","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4269\/ajtmh.2001.65.143","volume":"65","author":"M.D. Oh","year":"2001","unstructured":"Oh MD, Shin H, Shin D, et al.: Clinical features of vivax malaria. Am J Trop Med Hyg 2001, 65:143\u2013146.","journal-title":"Am J Trop Med Hyg"},{"key":"21_CR17","doi-asserted-by":"publisher","first-page":"719","DOI":"10.2165\/00003495-200059040-00001","volume":"59","author":"J.K. Baird","year":"2000","unstructured":"Baird JK: Resurgent malaria at the millennium: control strategies in crisis. Drugs 2000, 59:719\u2013743.","journal-title":"Drugs"},{"key":"21_CR18","doi-asserted-by":"publisher","first-page":"4075","DOI":"10.1128\/AAC.48.11.4075-4083.2004","volume":"48","author":"J.K. Baird","year":"2004","unstructured":"Baird JK: Resistance to chloroquine by Plasmodium vivax. Antimicrob Agents Chemother 2004, 48:4075\u20134083.","journal-title":"Antimicrob Agents Chemother"},{"key":"21_CR19","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1086\/342578","volume":"35","author":"J. Ling","year":"2002","unstructured":"Ling J, Baird JK, Fryauff DJ, et al.: Randomized, placebo-controlled trial of atovaquone\/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia. Clin Infect Dis 2002, 35:825\u2013833.","journal-title":"Clin Infect Dis"},{"key":"21_CR20","doi-asserted-by":"crossref","first-page":"430","DOI":"10.4269\/ajtmh.2006.75.430","volume":"75","author":"J. Soto","year":"2006","unstructured":"Soto J, Toledo J, Luzz M, et al.: Randomized, double-blind, placebo-controlled study of malarone for malaria prophylaxis in non-immune colombian soldiers. Am J Trop Med Hyg 2006, 75:430\u2013433.","journal-title":"Am J Trop Med Hyg"},{"key":"21_CR21","doi-asserted-by":"crossref","first-page":"963","DOI":"10.7326\/0003-4819-126-12-199706150-00006","volume":"126","author":"C. Ohrt","year":"1997","unstructured":"Ohrt C, Richie TL, Widjaja H, et al.: Mefloquine compared with doxycycline for the prophylaxis of malaria in Indonesian soldiers. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1997, 126:963\u2013972.","journal-title":"Ann Intern Med"},{"key":"21_CR22","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1086\/515071","volume":"28","author":"W.R. Taylor","year":"1999","unstructured":"Taylor WR, Richie TL, Fryauff DJ, et al.: Malaria prophylaxis using azithromycin: a double-blind, placebo-controlled trial in Irian Jaya, Indonesia. Clin Infect Dis 1999, 28:74\u201381.","journal-title":"Clin Infect Dis"},{"key":"21_CR23","first-page":"257","volume":"44","author":"E. Boudreau","year":"1993","unstructured":"Boudreau E, Schuster B, Sanchez J, et al.: Tolerability of prophylactic Lariam regimens. Trop Med Parasitol 1993, 44:257\u2013265.","journal-title":"Trop Med Parasitol"},{"key":"21_CR24","doi-asserted-by":"crossref","first-page":"402","DOI":"10.4269\/ajtmh.2006.75.402","volume":"75","author":"D.R. Hill","year":"2006","unstructured":"Hill DR, Baird JK, Parise ME, et al.: Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I. Am J Trop Med Hyg 2006, 75:402\u2013415.","journal-title":"Am J Trop Med Hyg"},{"key":"21_CR25","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1086\/424663","volume":"39","author":"J.K. Baird","year":"2004","unstructured":"Baird JK, Hoffman SL: Primaquine therapy for malaria. Clin Infect Dis 2004, 39:1336\u20131345.","journal-title":"Clin Infect Dis"},{"key":"21_CR26","doi-asserted-by":"crossref","first-page":"479","DOI":"10.4269\/ajtmh.1995.52.479","volume":"52","author":"J.K. Baird","year":"1995","unstructured":"Baird JK, Fryauff DJ, Basri H, et al.: Primaquine for prophylaxis against malaria among nonimmune transmigrants in Irian Jaya, Indonesia. Am J Trop Med Hyg, 1995, 52:479\u2013484.","journal-title":"Am J Trop Med Hyg"},{"key":"21_CR27","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/S0140-6736(95)92898-7","volume":"346","author":"D.J. Fryauff","year":"1995","unstructured":"Fryauff DJ, Baird JK, Basri H, et al.: Randomized, placebo-controlled trial of primaquine for prophylaxis of falciparum and vivax malaria in Indonesia. Lancet 1995, 346:1190\u20131193.","journal-title":"Lancet"},{"key":"21_CR28","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/infdis\/171.6.1569","volume":"171","author":"W.R. Weiss","year":"1995","unstructured":"Weiss WR, Oloo AJ, Johnson A, et al.: Daily primaquine is effective for prophylaxis against falciparum malaria in Kenya: comparison with mefloquine, doxycycline, and chloroquine plus proguanil. J Infect Dis 1995, 171:1569\u20131575.","journal-title":"J Infect Dis"},{"key":"21_CR29","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1086\/324085","volume":"33","author":"J.K. Baird","year":"2001","unstructured":"Baird JK, Lacy MD, Basri H, et al.: Randomized, parallel placebo-controlled trial of primaquine for malaria prophylaxis in Papua, Indonesia. Clin Infect Dis 2001, 33:1990\u20131997.","journal-title":"Clin Infect Dis"},{"key":"21_CR30","doi-asserted-by":"crossref","first-page":"241","DOI":"10.7326\/0003-4819-129-3-199808010-00013","volume":"129","author":"J. Soto","year":"1998","unstructured":"Soto J, Toledo J, Rodriquez M, et al.: Primaquine prophylaxis against malaria in nonimmune Colombian soldiers: efficacy and toxicity. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 1998, 129:241\u2013244.","journal-title":"Ann Intern Med"},{"key":"21_CR31","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1086\/313527","volume":"29","author":"E. Schwartz","year":"1999","unstructured":"Schwartz E, Regev-Yochay G: Primaquine as prophylaxis for malaria for non-immune travelers; comparison to mefloquine or doxycycline. Clin Infect Dis 1999, 29:1502\u20131506.","journal-title":"Clin Infect Dis"},{"key":"21_CR32","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S0035-9203(01)90206-8","volume":"95","author":"J.D. Berman","year":"2001","unstructured":"Berman JD, Nielsen R, Chulay JD, et al.: Causal prophylactic efficacy of atovaquone-proguanil (Malarone) in a human challenge model. Trans R Soc Trop Med Hyg 2001, 95:429\u2013432.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"21_CR33","first-page":"429","volume":"44","author":"J. Arnold","year":"1954","unstructured":"Arnold J, Alving AS, Hockwald RS, et al.: The effect of continuous and intermittent primaquine therapy on the relapse rate of Chesson strain vivax malaria. J Lab Clin Med 1954, 44:429\u2013438.","journal-title":"J Lab Clin Med"},{"key":"21_CR34","first-page":"391","volume":"46","author":"J. Arnold","year":"1955","unstructured":"Arnold J, Alving AS, Hockwald RS, et al.: The antimalarial action of primaquine against the blood and tissue stages of falciparum malaria. J Lab Clin Med 1955, 46:391\u2013397.","journal-title":"J Lab Clin Med"},{"key":"21_CR35","first-page":"203","volume":"7","author":"A.S. Alving","year":"1959","unstructured":"Alving AS, Rucker K, Flanagan CL, et al.: Observations on primaquine in the prophylaxis and cure of vivax malaria. Proc. 6th International Congress of Tropical Medicine and Malaria 1959, 7:203\u2013209.","journal-title":"Proc. 6th International Congress of Tropical Medicine and Malaria"},{"key":"21_CR36","doi-asserted-by":"crossref","first-page":"693","DOI":"10.4269\/ajtmh.1967.16.693","volume":"16","author":"R.D. Powell","year":"1967","unstructured":"Powell RD, Brewer GJ: The effects of pyrimethamine, chloroquine and primaquine against exoerythrocytic forms of a strain of chloroquine-resistant Plasmodium falciparum from Thailand. Am J Trop Med Hyg 1967, 16:693\u2013698.","journal-title":"Am J Trop Med Hyg"},{"key":"21_CR37","volume-title":"Health Information for International Travel 2003\u20132004","author":"Centers for Disease ControlPrevention","year":"2003","unstructured":"Centers for Disease Control and Prevention: Health Information for International Travel 2003\u20132004. Atlanta: US Department of Health and Human Services, Public Health Service; 2003."},{"key":"21_CR38","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1086\/379714","volume":"37","author":"J.K. Baird","year":"2003","unstructured":"Baird JK, Fryauff DJ, Hoffman SL: Primaquine for prevention of malaria in travelers. Clin Infect Dis 2003, 37:1659\u20131667.","journal-title":"Clin Infect Dis"},{"key":"21_CR39","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1001\/jama.1946.02870160015006","volume":"130","author":"R.F. Loeb","year":"1946","unstructured":"Loeb RF, Clark WM, Coatney GR, et al.: Activity of a new antimalarial agent, chloroquine (SN 7618). JAMA 1946, 130:1069\u20131070.","journal-title":"JAMA"},{"key":"21_CR40","doi-asserted-by":"crossref","first-page":"659","DOI":"10.4269\/ajtmh.2002.66.659","volume":"66","author":"J.K. Baird","year":"2002","unstructured":"Baird JK, Wiady I, Sutanihardja A, et al.: Short report: therapeutic efficacy of chloroquine combined with primaquine against Plasmodium falciparum in northeastern Papua, Indonesia. Am J Trop Med Hyg 2002, 66:659\u2013660.","journal-title":"Am J Trop Med Hyg"},{"key":"21_CR41","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/infdis\/169.4.932","volume":"169","author":"S. Pukrittayakamee","year":"1994","unstructured":"Pukrittayakamee S, Vanijononta S, Chantra A, et al.: Blood stage antimalarial efficacy of primaquine in Plasmodium vivax malaria. J Infect Dis 1994, 169:932\u2013935.","journal-title":"J Infect Dis"},{"key":"21_CR42","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/j.bcp.2005.07.021","volume":"70","author":"P.G. Bray","year":"2005","unstructured":"Bray PG, Deed S, Fox E, et al.: Primaquine synergises the activity of chloroquine against chloroquine-resistant P. falciparum. Biochem Pharmacol 2005, 70:1158\u20131166.","journal-title":"Biochem Pharmacol"},{"key":"21_CR43","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.actatropica.2003.10.012","volume":"89","author":"S. Pukrittayakamee","year":"2004","unstructured":"Pukrittayakamee S, Imwong M, Looareesuwan S, White NJ: Therapeutic responses to antimalarial and antibacterial drugs in vivax malaria. Acta Trop 2004, 89:351\u2013356.","journal-title":"Acta Trop"},{"key":"21_CR44","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.1086\/501357","volume":"42","author":"J.D. Maguire","year":"2006","unstructured":"Maguire JD, Krisin, Marwoto H, et al.: Mefloquine is highly efficacious against chloroquine-resistant Plasmodium vivax malaria and Plasmodium falciparum malaria in Papua, Indonesia. Clin Infect Dis 2006, 42:1067\u20131072.","journal-title":"Clin Infect Dis"},{"key":"21_CR45","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1086\/343750","volume":"35","author":"M.D. Lacy","year":"2002","unstructured":"Lacy MD, Maguire JD, Barcus, et al.: Atovaquone\/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity. Clin Infect Dis 2002, 35:92\u201395.","journal-title":"Clin Infect Dis"},{"key":"21_CR46","doi-asserted-by":"crossref","first-page":"970","DOI":"10.4269\/ajtmh.1953.2.970","volume":"6","author":"A.S. Alving","year":"1953","unstructured":"Alving AS, Hankey DD, Coatney GR, et al.: Korean vivax malaria. II. Curative treatment with pamaquine and primaquine. Am J Trop Med Hyg 1953, 6:970\u2013976.","journal-title":"Am J Trop Med Hyg"},{"key":"21_CR47","doi-asserted-by":"crossref","first-page":"958","DOI":"10.4269\/ajtmh.1953.2.958","volume":"2","author":"D.D. Hankey","year":"1953","unstructured":"Hankey DD, Jones Jr R, Coatney GR, et al.: Korean vivax malaria. I. Natural history and response to chloroquine. Am J Trop Med 1953, 2:958\u2013969.","journal-title":"Am J Trop Med"},{"key":"21_CR48","doi-asserted-by":"crossref","first-page":"985","DOI":"10.4269\/ajtmh.1953.2.985","volume":"6","author":"G.R. Coatney","year":"1953","unstructured":"Coatney GR, Alving AS, Jones R Jr, et al.: Korean vivax malaria. V. Cure of the infection by primaquine administered during long-term latency. Am J Trop Med Hyg 1953, 6:985\u2013988.","journal-title":"Am J Trop Med Hyg"},{"key":"21_CR49","doi-asserted-by":"crossref","first-page":"973","DOI":"10.4269\/ajtmh.1999.61.973","volume":"61","author":"P. Wilairatana","year":"1999","unstructured":"Wilairatana P, Silachamroon U, Krudsood S, et al.: Efficacy of primaquine regimens for primaquine-resistant Plasmodium vivax in Thailand. Am J Trop Med Hyg 1999, 61:973\u2013977.","journal-title":"Am J Trop Med Hyg"},{"key":"21_CR50","doi-asserted-by":"crossref","first-page":"322","DOI":"10.4269\/ajtmh.1995.52.322","volume":"52","author":"T. Jelinek","year":"1995","unstructured":"Jelinek T, Nothdurft HD, Von Sonnenburg F, Loscher T: Long-term efficacy of primaquine in the treatment of vivax malaria in nonimmune travelers. Am J Trop Med Hyg 1995, 52:322\u2013324.","journal-title":"Am J Trop Med Hyg"},{"key":"21_CR51","doi-asserted-by":"crossref","first-page":"393","DOI":"10.4269\/ajtmh.2000.62.393","volume":"62","author":"E. Schwartz","year":"2000","unstructured":"Schwartz E, Regev-Yochay G, Kurnik D: Considering primaquine dose adjustment for radical cure of Plasmodium vivax malaria. Am J Trop Med Hyg 2000, 62:393\u2013395.","journal-title":"Am J Trop Med Hyg"},{"key":"21_CR52","first-page":"621","volume":"22","author":"A.S. Alving","year":"1960","unstructured":"Alving AS, Johnson CF, Tarlov AR, et al.: Mitigation of the hemolytic effect of primaquine and enhancement of its action against exoerythrocytic forms of the Chesson strain of Plasmodium vivax by intermittent regimens of drug administration. Bull World Health Organ 1960, 22:621\u2013631.","journal-title":"Bull World Health Organ"},{"key":"21_CR53","first-page":"301","volume":"46","author":"A.S. Alving","year":"1955","unstructured":"Alving AS, Arnold J, Hockwald RS, et al.: Potentiation of the curative action of primaquine in vivax malaria by quinine and chloroquine. J Lab Clin Med 1955, 46:301\u2013306.","journal-title":"J Lab Clin Med"},{"key":"21_CR54","volume-title":"Malaria Vaccine Development: A Multi-Immune Response Approach","author":"S.L. Hoffman","year":"1996","unstructured":"Hoffman SL: Malaria Vaccine Development: A Multi-Immune Response Approach. Washington DC: American Society for Microbiology; 1996."},{"key":"21_CR55","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1038\/nm0598supp-520","volume":"4","author":"L.H. Miller","year":"1998","unstructured":"Miller LH, Hoffman SL: Research toward vaccines against malaria. Nat Med 1998, 4:520\u2013524.","journal-title":"Nat Med"},{"issue":"5Suppl","key":"21_CR56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4269\/ajtmh.2005.73.5_suppl.0730001","volume":"73","author":"E.S. Higgs","year":"2005","unstructured":"Higgs ES, Sina B: Plasmodium vivax vaccine research: steps in the right direction. Am J Trop Med Hyg 2005, 73(5 Suppl):1\u20132.","journal-title":"Am J Trop Med Hyg"},{"key":"21_CR57","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0014-4894(77)90142-4","volume":"41","author":"V.C. McCarthy","year":"1977","unstructured":"McCarthy VC, Clyde DF: Plasmodium vivax: correlation of circumsporozoite precipitation (CSP) reaction with sporozoite-induced protective immunity in man. Exp Parasitol 1977, 41:167\u2013171.","journal-title":"Exp Parasitol"},{"key":"21_CR58","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1126\/science.1704150","volume":"251","author":"Y. Charoenvit","year":"1991","unstructured":"Charoenvit Y, Collins WE, Jones TR, et al.: Inability of malaria vaccine to induce antibodies to a protective epitope within its sequence. Science 1991, 251:668\u2013671.","journal-title":"Science"},{"key":"21_CR59","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1084\/jem.156.1.20","volume":"156","author":"E.H. Nardin","year":"1982","unstructured":"Nardin EH, Nussenzweig V, Nussenzweig RS, et al.: Circumsprozoite proteins of human malaria parasites Plasmodium falciparum and Plasmodium vivax. J Exp Med 1982, 156:20\u201330.","journal-title":"J Exp Med"},{"key":"21_CR60","doi-asserted-by":"crossref","first-page":"455","DOI":"10.4269\/ajtmh.1989.40.455","volume":"40","author":"W.E. Collins","year":"1989","unstructured":"Collins WE, Nussenzweig RS, Ballou WR, et al.: Immunization of protein of Plasmodium vivax. Am J Trop Med Hyg 1989, 40:455\u2013464.","journal-title":"Am J Trop Med Hyg"},{"key":"21_CR61","doi-asserted-by":"crossref","first-page":"200","DOI":"10.4269\/ajtmh.1997.56.200","volume":"56","author":"W.E. Collins","year":"1997","unstructured":"Collins WE, Sullivan JS, Morris CL, et al.: Protective immunity induced in squirrel monkeys with a multiple antigen construct against the circumsporozoite protein of Plasmodium vivax. Am J Trop Med Hyg 1997, 56:200\u2013210.","journal-title":"Am J Trop Med Hyg"},{"key":"21_CR62","doi-asserted-by":"crossref","first-page":"642","DOI":"10.4269\/ajtmh.2004.70.642","volume":"70","author":"W.E. Collins","year":"2004","unstructured":"Collins WE, Jeffery GM, Roberts JM: A retrospective examination of reinfection of humans with Plasmodium vivax. Am J Trop Med Hyg 2004, 70:642\u2013644.","journal-title":"Am J Trop Med Hyg"}],"container-title":["Current Infectious Disease Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-007-0021-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11908-007-0021-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-007-0021-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11908-007-0021-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T21:28:50Z","timestamp":1744147730000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11908-007-0021-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["21"],"URL":"https:\/\/doi.org\/10.1007\/s11908-007-0021-4","relation":{},"ISSN":["1523-3847","1534-3146"],"issn-type":[{"value":"1523-3847","type":"print"},{"value":"1534-3146","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,1]]},"assertion":[{"value":"17 April 2007","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}